| Mortality after hospitalization for COPD P Almagro, E Calbo, AO de Echaguïen, B Barreiro, S Quintana, ... Chest 121 (5), 1441-1448, 2002 | 850 | 2002 |
| A Multinational Survey of Risk Factors for Infection with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Nonhospitalized Patients R Ben-Ami, J Rodríguez-Baño, H Arslan, JDD Pitout, C Quentin, ES Calbo, ... Clinical Infectious Diseases 49 (5), 682-690, 2009 | 689 | 2009 |
| Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective … B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... The Lancet Infectious Diseases 17 (7), 726-734, 2017 | 506 | 2017 |
| Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum β-lactamases E Calbo, V Romaní, M Xercavins, L Gómez, CG Vidal, S Quintana, J Vila, ... Journal of Antimicrobial Chemotherapy 57 (4), 780-783, 2006 | 494 | 2006 |
| Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH J Rodríguez-Baño, JR Pano-Pardo, L Alvarez-Rocha, Á Asensio, E Calbo, ... Enfermedades infecciosas y microbiologia clinica 30 (1), 22. e1-22. e23, 2012 | 338 | 2012 |
| An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance ST Micek, RG Wunderink, MH Kollef, C Chen, J Rello, J Chastre, ... Critical Care 19, 1-8, 2015 | 305 | 2015 |
| Influence of Virulence Genotype and Resistance Profile in the Mortality of Pseudomonas aeruginosa Bloodstream Infections C Peña, G Cabot, S Gómez-Zorrilla, L Zamorano, A Ocampo-Sosa, ... Clinical Infectious Diseases 60 (4), 539-548, 2015 | 234 | 2015 |
| Effects of systemic steroids in patients with severe community-acquired pneumonia C Garcia-Vidal, E Calbo, V Pascual, C Ferrer, S Quintana, J Garau European Respiratory Journal 30 (5), 951-956, 2007 | 212 | 2007 |
| Effect of Adequate Single-Drug vs Combination Antimicrobial Therapy on Mortality in Pseudomonas aeruginosa Bloodstream Infections: A Post Hoc Analysis of a … C Peña, C Suarez, A Ocampo-Sosa, J Murillas, B Almirante, V Pomar, ... Clinical infectious diseases 57 (2), 208-216, 2013 | 190 | 2013 |
| Foodborne Nosocomial Outbreak of SHV1 and CTX-M-15–producing Klebsiella pneumoniae: Epidemiology and Control E Calbo, N Freixas, M Xercavins, M Riera, C Nicolás, O Monistrol, ... Clinical infectious diseases 52 (6), 743-749, 2011 | 188 | 2011 |
| A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase … B Gutiérrez-Gutiérrez, S Perez-Galera, E Salamanca, M De Cueto, ... Antimicrobial agents and chemotherapy 60 (7), 4159-4169, 2016 | 179 | 2016 |
| Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era … JP Horcajada, E Shaw, B Padilla, V Pintado, E Calbo, N Benito, ... Clinical microbiology and infection 19 (10), 962-968, 2013 | 166 | 2013 |
| Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections C Peña, C Suarez, M Gozalo, J Murillas, B Almirante, V Pomar, M Aguilar, ... Antimicrobial agents and chemotherapy 56 (3), 1265-1272, 2012 | 166 | 2012 |
| Programs for optimizing the use of antibiotics (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document J Rodríguez-Baño, JR Paño-Pardo, L Alvarez-Rocha, A Asensio, E Calbo, ... Farmacia hospitalaria: organo oficial de expresion cientifica de la Sociedad …, 2011 | 159 | 2011 |
| Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine E Calbo, A Diaz, E Canadell, J Fábrega, S Uriz, M Xercavins, MA Morera, ... Clinical Microbiology and Infection 12 (9), 867-872, 2006 | 157 | 2006 |
| Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19) J Rodríguez-Baño, J Pachón, J Carratala, P Ryan, I Jarrín, M Yllescas, ... Clinical Microbiology and Infection 27 (2), 244-252, 2021 | 144 | 2021 |
| Bloodstream infections in adults: importance of healthcare-associated infections J Vallés, E Calbo, E Anoro, D Fontanals, M Xercavins, E Espejo, ... Journal of infection 56 (1), 27-34, 2008 | 132 | 2008 |
| Of mice and men: innate immunity in pneumococcal pneumonia E Calbo, J Garau International journal of antimicrobial agents 35 (2), 107-113, 2010 | 111 | 2010 |
| A predictive model of mortality in patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... Mayo Clinic Proceedings 91 (10), 1362-1371, 2016 | 107 | 2016 |
| GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 E Pairo-Castineira, K Rawlik, AD Bretherick, T Qi, Y Wu, I Nassiri, ... Nature 617 (7962), 764-768, 2023 | 106 | 2023 |
Javier GarauAssociate Professor of Medicine, University of Barcelona在 clinicarotger.es 的电子邮件经过验证
